Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 269,811 | 287,057 | 51,704 | 79,655 | 142,304 |
| Marketable Securities | 124,902 | 175,225 | 63,191 | 49,195 | N/A |
| Receivables | 32,441 | 36,012 | 19,660 | 16,560 | 15,119 |
| Inventories | 42,618 | 40,359 | 20,533 | 21,927 | 22,080 |
| TOTAL | $480,029 | $547,565 | $158,215 | $170,741 | $183,070 |
| Non-Current Assets | |||||
| PPE Net | 42,569 | 44,786 | 24,187 | 24,538 | 24,522 |
| Intangibles | 130,331 | 131,063 | 107,717 | 110,425 | 113,287 |
| Other Non-Current Assets | 55,803 | 54,253 | 32,948 | 33,581 | 34,948 |
| TOTAL | $228,703 | $230,102 | $164,852 | $168,544 | $172,757 |
| Total Assets | $708,732 | $777,667 | $323,067 | $339,285 | $355,827 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 5,000 | 5,000 | 4,583 |
| Accounts payable and accrued liabilities | 12,570 | 13,141 | 9,236 | 7,327 | 6,089 |
| Accrued Expenses | 31,929 | 30,430 | 21,019 | 10,423 | 9,765 |
| TOTAL | $123,808 | $121,554 | $109,327 | $51,800 | $46,840 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 3,414 | 4,615 | 5,809 |
| Deferred Revenues | 18,675 | 17,493 | 15,219 | 14,871 | 15,315 |
| Other Non-Current Liabilities | 31,432 | 34,227 | 32,008 | 87,211 | 87,927 |
| TOTAL | $74,663 | $78,797 | $50,538 | $107,952 | $111,121 |
| Total Liabilities | $198,471 | $200,351 | $159,865 | $159,752 | $157,961 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 371,155 | 372,142 | 290,118 | 79,395 | 78,965 |
| Common Shares | 389 | 387 | 83 | 82 | 81 |
| Retained earnings | -1,124,641 | -1,078,923 | -1,000,752 | -980,976 | -959,979 |
| Other shareholders' equity | -1,967 | -1,820 | 309,055 | 309,501 | 309,298 |
| TOTAL | $510,261 | $577,316 | $163,202 | $179,533 | $197,866 |
| Total Liabilities And Equity | $708,732 | $777,667 | $323,067 | $339,285 | $355,827 |